Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIKI-C study of nebulized ketamine after cardiac surgery in ICU
ACTRN12625000579493Phase 2Not yet recruiting
- Sponsor
- The University of Queensland
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ketamine in postoperative pain, sponsored by The University of Queensland. Primary endpoints: Plasma ketamine pharmacokinetics and Urine creatinine clearance and renal excretion. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12625000579493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000579493.